Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$778M |
| 2 |
Walt Disney
DIS
|
+$575M |
| 3 |
Amazon
AMZN
|
+$558M |
| 4 |
Applied Materials
AMAT
|
+$373M |
| 5 |
eBay
EBAY
|
+$349M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$669M |
| 2 |
Philip Morris
PM
|
+$454M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 4 |
Marvell Technology
MRVL
|
+$371M |
| 5 |
Qualcomm
QCOM
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.2% |
| 2 | Financials | 10.85% |
| 3 | Healthcare | 9.88% |
| 4 | Industrials | 8.88% |
| 5 | Consumer Discretionary | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Vir Biotechnology
VIR
$1.48B
| $3.27M | ﹤0.01% |
322,576
+9,824
| +3% | +$100K |
|
2552
MarineMax
HZO
$776M
| $3.27M | ﹤0.01% |
98,242
-2,161
| -2% | -$69.2K |
|
2553
ENI
E
$78.6B
| $3.26M | ﹤0.01% |
102,595
-2,067
| -2% | -$65.5K |
|
2554
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
| $3.25M | ﹤0.01% |
68,162
+36,295
| +114% | +$1.66M |
|
|
OSG
2555
Octave Specialty Group
OSG
$255M
| $3.25M | ﹤0.01% |
207,715
+18,379
| +10% | +$290K |
|
2556
Mativ Holdings
MATV
$644M
| $3.24M | ﹤0.01% |
172,700
+2,379
| +1% | +$35.5K |
|
|
IBTF
2557
DELISTED
iShares iBonds Dec 2025 Term Treasury ETF
IBTF
| $3.24M | ﹤0.01% |
139,391
+47,281
| +51% | +$1.1M |
|
2558
Embecta
EMBC
$208M
| $3.23M | ﹤0.01% |
243,668
+61,248
| +34% | +$949K |
|
2559
Valens Semiconductor
VLN
$182M
| $3.23M | ﹤0.01% |
1,373,512
+69,468
| +5% | +$158K |
|
2560
First Merchants
FRME
$2.69B
| $3.22M | ﹤0.01% |
92,162
-16,058
| -15% | -$551K |
|
|
FLG
2561
Flagstar Bank National Association
FLG
$5.9B
| $3.21M | ﹤0.01% |
332,224
-1,563,628
| -82% | -$28.9M |
|
2562
FlexShares STOXX Global ESG Select Index Fund
ESGG
$114M
| $3.2M | ﹤0.01% |
19,662
+1,956
| +11% | +$305K |
|
2563
Health Catalyst
HCAT
$171M
| $3.2M | ﹤0.01% |
425,155
-19,574
| -4% | -$179K |
|
2564
XPEL
XPEL
$1.31B
| $3.2M | ﹤0.01% |
59,249
-3,087
| -5% | -$162K |
|
2565
Harmony Biosciences
HRMY
$2.26B
| $3.2M | ﹤0.01% |
95,150
-3,916
| -4% | -$126K |
|
2566
BRC Group Holdings
RILY
$292M
| $3.19M | ﹤0.01% |
150,841
+24,477
| +19% | +$491K |
|
|
KW
2567
DELISTED
Kennedy-Wilson Holdings
KW
| $3.19M | ﹤0.01% |
370,916
+23,192
| +7% | +$228K |
|
2568
Titan International
TWI
$465M
| $3.19M | ﹤0.01% |
255,622
-2,636
| -1% | -$36.2K |
|
2569
Sixth Street Specialty
TSLX
$1.78B
| $3.18M | ﹤0.01% |
148,288
+30,107
| +25% | +$647K |
|
2570
National Beverage
FIZZ
$2.99B
| $3.17M | ﹤0.01% |
66,813
-4,575
| -6% | -$224K |
|
2571
Ambarella
AMBA
$3.68B
| $3.17M | ﹤0.01% |
62,416
-6,274
| -9% | -$342K |
|
2572
Element Solutions
ESI
$9.37B
| $3.16M | ﹤0.01% |
126,585
-31,574
| -20% | -$734K |
|
2573
Ezcorp Inc
EZPW
$1.8B
| $3.16M | ﹤0.01% |
279,042
-17,730
| -6% | -$175K |
|
|
TBNK
2574
DELISTED
Territorial Bancorp Inc.
TBNK
| $3.16M | ﹤0.01% |
391,720
-3,697
| -0.9% | -$35.6K |
|
2575
Nuveen Quality Municipal Income Fund
NAD
$2.76B
| $3.12M | ﹤0.01% |
272,515
-149,212
| -35% | -$1.69M |
|
Similar funds
Ameriprise's Q1 2024 Portfolio in Review
As of Q1 2024, Ameriprise held 4,016 positions worth $363B, up 8.8% from $334B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Ameriprise's Q1 2024 filing shows 118 new, 1,585 increased, 2,002 reduced and 175 closed positions. Its largest new stake was Arcadium Lithium plc: 13,685,562 shares worth $59M. The largest sale was Lam Research, an estimated $669M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q1 2024 buy was Arcadium Lithium plc: 13,685,562 shares worth $59M.
- Ameriprise added most to Meta Platforms (Facebook) in Q1 2024, an estimated $778M increase.
- Ameriprise's biggest Q1 2024 reduction was Lam Research, cutting an estimated $669M.
- Ameriprise fully exited Livent Corporation in Q1 2024, selling an estimated $120M.
- Ameriprise's ten largest holdings make up 18% of its $363B portfolio in Q1 2024.
- Ameriprise opened 118 new positions and closed 175 in Q1 2024.
- Ameriprise's portfolio value rose 8.8% quarter-over-quarter to $363B.
Based on Ameriprise's 13F filing for Q1 2024, filed 15 May 2024.